40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.48%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
56.29%
Positive gross profit growth while CVE is negative. John Neff would see a clear operational edge over the competitor.
100.00%
Positive EBIT growth while CVE is negative. John Neff might see a substantial edge in operational management.
674.16%
Positive operating income growth while CVE is negative. John Neff might view this as a competitive edge in operations.
293.08%
Positive net income growth while CVE is negative. John Neff might see a big relative performance advantage.
295.08%
Positive EPS growth while CVE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
293.44%
Positive diluted EPS growth while CVE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.54%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.12%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.75%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-100.00%
Negative OCF growth while CVE is at 80.53%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-303.52%
Negative FCF growth while CVE is at 1306.98%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
81.41%
Positive 10Y revenue/share CAGR while CVE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
220.27%
Positive 5Y CAGR while CVE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-38.39%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Negative 5Y OCF/share CAGR while CVE is at 100.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
112.39%
Positive 10Y CAGR while CVE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
107.03%
5Y net income/share CAGR similar to CVE's 100.00%. Walter Schloss might see both on parallel mid-term trajectories.
-77.53%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-13.77%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
77.24%
Positive 5Y equity/share CAGR while CVE is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
77.03%
Positive short-term equity growth while CVE is negative. John Neff sees a strong advantage in near-term net worth buildup.
35.18%
Stable or rising dividend while CVE is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
208.95%
Dividend/share CAGR of 208.95% while CVE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
19.48%
Our short-term dividend growth is positive while CVE cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
272.06%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.50%
Positive BV/share change while CVE is negative. John Neff sees a clear edge over a competitor losing equity.
-2.50%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.